Targeted therapeutics are an invaluable tool for improving clinical outcomes in a range of diseases, but the development process is laborious, time-consuming, and costly. Therefore, researchers seek ways to streamline targeted therapeutic development workflows. Laboratory imagers address the growing need for reliable, efficient, cost-effective technologies to support all stages of targeted therapeutic development, including discovery, screening, lead optimization, and preclinical testing.
Download this ebook from LI-COR to learn how the latest cutting-edge imagers improve targeted therapeutic development workflows.
